Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionEarly phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.Research progress of neuroblastoma related gene variations.Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment.
P2860
Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@en
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@nl
type
label
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@en
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@nl
prefLabel
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@en
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@nl
P2093
P2860
P1433
P1476
Novel pharmacodynamic biomarke ...... n children with neuroblastoma.
@en
P2093
Andrew D J Pearson
Jennifer R Smith
Lucas Moreno
Michelle D Garrett
P2860
P304
P356
10.1016/J.MOLONC.2015.11.005
P577
2015-11-19T00:00:00Z